カドミウムや他の微量金属がヒトのアルファ1-アンチトリプシンに及ぼす影響:インビトロ研究
Science (New York, N.Y.)
|February 6, 1976
まとめ
カドミウムへの暴露は,アルファ1-抗トリプシンレベルを大幅に低下させ,トリプシン抑制能力を低下させます. この発見は,カドミウムにさらされた産業労働者の肺腫を説明する可能性がある.
科学分野:
- バイオケミストリー バイオケミストリー
- 毒理学 毒理学 毒理学
- 職業衛生は,健康に関するものです.
背景:
- アルファ1-アンチトリプシン (AAT) は,プラズマにおける重要なプロテアゼ阻害剤である.
- エンフィゼマは重篤な肺疾患で,しばしば環境への曝露に関連しています.
- 様々な微量金属がAAT機能に与える影響は完全に理解されていません.
研究 の 目的:
- プラズマアルファ1-アンチトリプシン濃度および機能に対する異なる微量金属のインビトロ効果を調査する.
- カドミウム曝露がアルファ1-アンチトリプシン活性低下と関連しているかどうかを判断する.
主な方法:
- ヒトの血は,それぞれまたは組み合わせて,様々な微量金属 (カドミウム,鉛,水銀,ニッケル,鉄,亜鉛) の既知の濃度で処理されました.
- アルファ1-アンチトリプシン濃度は,標準的な生化学分析を用いて測定された.
- トリプシン抑制能力は,AATの機能的活動を評価するために評価されました.
主要な成果:
- カドミウムは,プラズマアルファ1-アンチトリプシン濃度を著しく低下させた唯一のテストされた微量金属でした.
- カドミウムはまた,プラズマのトリプシン抑制能力を著しく低下させた.
- 鉛,水銀,ニッケル,鉄,亜鉛の二価イオンは,アルファ1-アンチトリプシンにそのような効果を示さなかった.
結論:
- カドミウムへの暴露は,肺の保護に不可欠なタンパク質であるアルファ1-アンチトリプシンに悪影響を及ぼす.
- これらの発見は,産業労働者におけるカドミウム曝露と肺腫の発症を結びつける潜在的な生化学的メカニズムを提供する.
関連する概念動画
01:27The Periodic Table and Organismal Elements
Elements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally occurring, and only a few of them are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.
Periodic Table Provides Information...
Periodic Table Provides Information...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...